These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38941516)

  • 1. Tyrosine Sulfation Modulates the Binding Affinity of Chemokine-Targeting Nanobodies.
    Dilly JJ; Morgan AL; Bedding MJ; Low JKK; Mackay JP; Conibear AC; Bhusal RP; Stone MJ; Franck C; Payne RJ
    ACS Chem Biol; 2024 Jul; 19(7):1426-1432. PubMed ID: 38941516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural role of receptor tyrosine sulfation in chemokine recognition.
    Ludeman JP; Stone MJ
    Br J Pharmacol; 2014 Mar; 171(5):1167-79. PubMed ID: 24116930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3.
    Zhu JZ; Millard CJ; Ludeman JP; Simpson LS; Clayton DJ; Payne RJ; Widlanski TS; Stone MJ
    Biochemistry; 2011 Mar; 50(9):1524-34. PubMed ID: 21235238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease.
    Liu J; Louie S; Hsu W; Yu KM; Nicholas HB; Rosenquist GL
    Am J Respir Cell Mol Biol; 2008 Jun; 38(6):738-43. PubMed ID: 18218997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfation of the Human Cytomegalovirus Protein UL22A Enhances Binding to the Chemokine RANTES.
    Wang X; Sanchez J; Stone MJ; Payne RJ
    Angew Chem Int Ed Engl; 2017 Jul; 56(29):8490-8494. PubMed ID: 28488292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.
    Stone MJ; Payne RJ
    Acc Chem Res; 2015 Aug; 48(8):2251-61. PubMed ID: 26196117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
    Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
    FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semisynthesis of an evasin from tick saliva reveals a critical role of tyrosine sulfation for chemokine binding and inhibition.
    Franck C; Foster SR; Johansen-Leete J; Chowdhury S; Cielesh M; Bhusal RP; Mackay JP; Larance M; Stone MJ; Payne RJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12657-12664. PubMed ID: 32461364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function.
    Blanchetot C; Verzijl D; Mujić-Delić A; Bosch L; Rem L; Leurs R; Verrips CT; Saunders M; de Haard H; Smit MJ
    J Biol Chem; 2013 Aug; 288(35):25173-25182. PubMed ID: 23836909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines.
    Bannert N; Craig S; Farzan M; Sogah D; Santo NV; Choe H; Sodroski J
    J Exp Med; 2001 Dec; 194(11):1661-73. PubMed ID: 11733580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Glyco-sulfo barcodes" regulate chemokine receptor function.
    Verhallen L; Lackman JJ; Wendt R; Gustavsson M; Yang Z; Narimatsu Y; Sørensen DM; Lafferty KM; Gouwy M; Marques PE; Hjortø GM; Rosenkilde MM; Proost P; Goth CK
    Cell Mol Life Sci; 2023 Feb; 80(2):55. PubMed ID: 36729338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties.
    Scurci I; Akondi KB; Pinheiro I; Paolini-Bertrand M; Borgeat A; Cerini F; Hartley O
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129753. PubMed ID: 32991968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 7. Tyrosine sulfation of HIV-1 coreceptors and other chemokine receptors.
    Choe H; Farzan M
    Methods Enzymol; 2009; 461():147-70. PubMed ID: 19480918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphate modulates receptor sulfotyrosine recognition by the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2).
    Ludeman JP; Nazari-Robati M; Wilkinson BL; Huang C; Payne RJ; Stone MJ
    Org Biomol Chem; 2015 Feb; 13(7):2162-9. PubMed ID: 25536525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a framework for sulfoproteomics: Synthesis and characterization of sulfotyrosine-containing peptides.
    Seibert C; Sakmar TP
    Biopolymers; 2008; 90(3):459-77. PubMed ID: 17680702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.
    Hewit KD; Fraser A; Nibbs RJ; Graham GJ
    J Biol Chem; 2014 May; 289(18):12330-42. PubMed ID: 24644289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine sulfation: a modulator of extracellular protein-protein interactions.
    Kehoe JW; Bertozzi CR
    Chem Biol; 2000 Mar; 7(3):R57-61. PubMed ID: 10712936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfated tyrosines 27 and 29 in the N-terminus of human CXCR3 participate in binding native IP-10.
    Gao JM; Xiang RL; Jiang L; Li WH; Feng QP; Guo ZJ; Sun Q; Zeng ZP; Fang FD
    Acta Pharmacol Sin; 2009 Feb; 30(2):193-201. PubMed ID: 19151743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of tyrosine sulfation in seven-transmembrane peptide receptors.
    Yu KM; Liu J; Moy R; Lin HC; Nicholas HB; Rosenquist GL
    Endocrine; 2002 Dec; 19(3):333-8. PubMed ID: 12624435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte chemotactic protein-1 receptor CCR2B is a glycoprotein that has tyrosine sulfation in a conserved extracellular N-terminal region.
    Preobrazhensky AA; Dragan S; Kawano T; Gavrilin MA; Gulina IV; Chakravarty L; Kolattukudy PE
    J Immunol; 2000 Nov; 165(9):5295-303. PubMed ID: 11046064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.